Literature DB >> 24001533

Two Year SAVE Outcomes: 2.0 mg ranibizumab for recalcitrant neovascular AMD.

Charles C Wykoff1, David M Brown, Daniel E Croft, Tien P Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24001533     DOI： 10.1016/j.ophtha.2013.06.030

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  6 in total

1.  One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement.

Authors:  Toshiaki Hirakata; Kaoru Fujinami; Ken Watanabe; Mariko Sasaki; Toru Noda; Kunihiko Akiyama
Journal:  Clin Ophthalmol       Date:  2016-05-26

Review 2.  Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives.

Authors:  Hyeong Min Kim; Se Joon Woo
Journal:  Pharmaceutics       Date:  2021-01-15       Impact factor: 6.321

3.  Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.

Authors:  Emily Li; Simone Donati; Kristina B Lindsley; Magdalena G Krzystolik; Gianni Virgili
Journal:  Cochrane Database Syst Rev       Date:  2020-05-05

4.  Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial).

Authors:  Charles C Wykoff; David M Brown; Maria E Maldonado; Daniel E Croft
Journal:  Br J Ophthalmol       Date:  2014-02-11       Impact factor: 4.638

5.  Intraocular Pharmacokinetics of 10-fold Intravitreal Ranibizumab Injection Dose in Rabbits.

Authors:  Hyeong Min Kim; Young Joo Park; Simin Lee; Joo Young Son; Hye Kyoung Hong; Min Hee Ham; Xuanyou Jin; Jae Yong Chung; Kyu Hyung Park; Ki Dong Park; Se Joon Woo
Journal:  Transl Vis Sci Technol       Date:  2020-03-09       Impact factor: 3.283

6.  Short-term results of early switch from Ranibizumab to Aflibercept in poor or non responder age related macular degeneration in clinical practice.

Authors:  Luciana de Sá Quirino-Makarczyk; Maria de Fátima Sainz Ugarte; Bruna Viana Vieira; Sérgio Kniggendorf; Caio Vinicius Saito Regatieri
Journal:  Int J Retina Vitreous       Date:  2020-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.